Luiz F. Carvalho

Clarity Healthcare Intelligence, Marginal Via Anhanguera, 480, Engordadouro
Jundiai, SP 13214658, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Lipoprotein Subfractions and Coronary Artery Calcium Progression: Insights from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Lipoprotein Subfractions and Coronary Artery Calcium Progression: Insights from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Journal: European journal of preventive cardiology

Published: February 12, 2026

Regional inequities in myocardial infarction burden in Brazil's public healthcare system.

Regional inequities in myocardial infarction burden in Brazil's public healthcare system.

Journal: Archives of public health = Archives belges de sante publique

Published: January 24, 2026

A contemporary overview of emergency myocardial infarction hospitalizations with primary percutaneous coronary intervention in Brazil: regional trends of costs and outcomes.

A contemporary overview of emergency myocardial infarction hospitalizations with primary percutaneous coronary intervention in Brazil: regional trends of costs and outcomes.

Journal: Archives of public health = Archives belges de sante publique

Published: May 27, 2025

Cross-cultural similarities and differences in level of personality functioning across eight countries.

Cross-cultural similarities and differences in level of personality functioning across eight countries.

Journal: Psychology, health & medicine

Published: May 13, 2025

Pan-genome and haplotype map of cassava cultivars and wild ancestors provide insights into its adaptive evolution and domestication.

Pan-genome and haplotype map of cassava cultivars and wild ancestors provide insights into its adaptive evolution and domestication.

Journal: Molecular plant

Published: May 11, 2024

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.

Journal: International journal of molecular sciences

Published: February 16, 2024

Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.

Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.

Journal: Molecular genetics and metabolism

Published: October 18, 2022

Artificial Intelligence in Allergy and Immunology: Comparing Risk Prediction Models to Help Screen Inborn Errors of Immunity.

Artificial Intelligence in Allergy and Immunology: Comparing Risk Prediction Models to Help Screen Inborn Errors of Immunity.

Journal: International archives of allergy and immunology

Published: May 26, 2022

Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes.

Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes.

Journal: Current medical research and opinion

Published: February 17, 2022

Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis.

Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis.

Journal: Diagnostics (Basel, Switzerland)

Published: February 07, 2022

Orchestrating a ceramide-phosphatidylcholine cardiovascular risk score: it ain't over 'til the fat layer sings.

Orchestrating a ceramide-phosphatidylcholine cardiovascular risk score: it ain't over 'til the fat layer sings.

Journal: European journal of preventive cardiology

Published: May 26, 2021

Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial.

Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial.

Journal: Diabetes & metabolism

Published: May 10, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026